abatacept vs buprenorphine (pain)
Side-by-side comparison of abatacept and buprenorphine (pain) Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Orencia
Belbuca, Butrans
Orencia is a medicine that helps to reduce inflammation. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis.
Belbuca is a medicine used to treat severe, long-lasting pain. It contains buprenorphine, a type of opioid pain reliever.
Orencia treats rheumatoid arthritis in adults. It also treats polyarticular juvenile idiopathic arthritis in patients 2 years and older. Orencia can also treat active psoriatic arthritis in patients 2 years and older. Finally, it can prevent acute graft versus host disease after a stem cell transplant.
Belbuca is used to manage severe, ongoing pain that needs an opioid medicine. It is for pain that cannot be well-treated with other options, like immediate-release opioids. Because of the risks of addiction, abuse, misuse, overdose, and death, Belbuca should only be used if other treatments don't work, aren't tolerated, or aren't enough to manage your pain.
Orencia works by blocking the activity of certain immune cells called T cells. These T cells can cause inflammation and damage to your joints and other tissues. By blocking T cell activity, Orencia can help reduce inflammation and relieve your symptoms.
Belbuca contains buprenorphine, which is a partial opioid agonist. It works by attaching to certain receptors in the brain and body. This helps to decrease the feeling of pain.
- • Headache
- • Upper respiratory tract infection (like a cold)
- • Runny nose
- • Nausea
- • Nausea
- • Constipation
- • Headache
- • Vomiting
- • Dizziness
- The medicine is not working 38,612
- Rheumatoid arthritis 23,596
- Pain 21,295
- Joint pain 20,151
- Swollen joint 19,709
No adverse event reports.
Using Orencia with a TNF antagonist or other biologic medicines can raise your risk of serious infections. Tell your doctor if you have any signs of infection, such as fever, cough, or sore throat. Orencia can also cause allergic reactions, including anaphylaxis. Get medical help right away if you have trouble breathing, swelling, or hives.
Belbuca can lead to addiction, abuse, and misuse, which can result in overdose and death. It can also cause serious, life-threatening breathing problems, especially when you first start taking it or after a dose increase. Accidental exposure, especially in children, can be fatal. Taking Belbuca with benzodiazepines (like Xanax or Valium) or other depressants (including alcohol) can cause severe sleepiness, breathing problems, coma, and death. If you are pregnant and use Belbuca for a long time, your baby could have withdrawal symptoms after birth.
There is not enough information about Orencia use in pregnant women to know if it is safe. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Using Belbuca for a long time during pregnancy can cause withdrawal symptoms in the newborn. Talk to your doctor if you are pregnant or plan to become pregnant. Breastfeeding is not recommended while using Belbuca.
Also Compare — Nearby Drugs
Compare buprenorphine (pain) with
How to Read This abatacept vs buprenorphine (pain) Comparison
abatacept is classified in the T-Cell Co-Stimulation Modulator drug class, while buprenorphine (pain) sits within the Partial Opioid Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abatacept has 123,363 submissions while buprenorphine (pain) has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abatacept and buprenorphine (pain) — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.